Académique Documents
Professionnel Documents
Culture Documents
Otorhinolaryngology
Vol.17, No.41,Autumn-2005
1384
1,2,3
SI
Abstract
Ar
ch
ive
of
Introduction: In cases with lacrimal gland mixed tumor preoperative delicate clinical and radiological
diagnosis lead to proper surgical approach. Incomplete resection of lacrimal gland mixed tumor may
be complicated by severe tumor recurrence with the risk of malignant transformation.
In this case report, we present 39 years old man with history of transcranial excision of lacrimal gland
tumor. Six months before admission progressive proptosis and inferomedial displacement of right
globe (approximately 3 cm) has been developed. Soft tissue hypertrophy of eyelids and corneal
leukoma developed due to the chronic progressive course of proptosis with chronic corneal exposure.
The other case also was a 38-year-old man with significant proptosis and history of two time lacrimal
gland tumor excision, one from transcranial approach.
The surgical procedure was performed in both cases through anterolateral orbitotomy without bone
removal and the whole lesions were removed with pseudo capsule.
The vision of the first patient improved from hand motion preoperatively to one meter finger count
after surgery, and there was no recurrence in both cases 6 months postoperatively.
In general, regarding risk of malignant degeneration and recurrence after incomplete excision or
incisional biopsy of lacrimal gland mixed tumor, it is strongly recommended to perform complete
excision with psudocapsule in the first surgery.
Key words: Pleomorphic adenoma, Lacrimal gland, Tumor recurrence, Benign Mixed Tumor
Introduction
Page 9-14
www.SID.ir
No.41, Autumn-2005
Examination of ocular motility showed
significant limitation of ductions of the right
eye in upward and outward rotation.
In computerized tomography, a large
multilobulated lesion with involvement of
superolateral region of right orbit can be
seen. The tumor diameter was approximately
4 cm. defect of orbital roof bone noted on
CT and heterogeneous radiodensity with
area of calcification are visible. The globe
displaced inferiorly about 3cm that
presented on CT and there is no significant
sign of any bone erosion. (Fig 2 a&b)
ch
ive
of
SI
Ar
A: preoperative
Fig.1: Photographs of the first case with
recurrence of pleomorphic adenoma of lacrimal
gland
www.SID.ir
pleomorphic
Fig.4:Light
microscopy
of
adenoma (H&E stain, mag 100x)
SI
of
Ar
ch
ive
B: postoperative
pleomorphic
www.SID.ir
No.41, Autumn-2005
epithelial lacrimal gland tumors, primary
intervention should consist of complete
removal of the tumor without a preliminary
biopsy (2, 3,4).
Incisional biopsy of the lesion and violation
of the capsule of the pelomorphic adenoma
increased recurrence rate and risk of
malignant degeneration (5).
Regarding anatomical location of lacrimal
gland in superolateral region of the orbit
beneath the superior orbital rim, in spite of
extension of large tumors to orbital apex,
preferred surgical approach is though
anterolateral
orbitotomies.
When
a
pleomorphic adenoma is suspected on the
basis
of
clinical
and
radiological
appearances,the tumor with a rim of
surrounding normal tissues should be
removed without prior biopsy. This ensures
excision of any nodules extending outside
the main tumor; recurrence following
incomplete removal takes the form of
multiple scattered nodules (5,6,7,8).
Although in our cases the surfaces of lesions
are also multilobulated, histologically the
tumor is biphasic, with epithelial and
stromal elements.The epithelial portion is
composed of small ductules with an inner
cuboidal to columnar layer and an outer
spindle-shaped layer that often contains
clear cells. Squamous metaplasia may be
present.The outer layers show a gradual
transition to mesenchymal tissues, which
may display mioxoid, cartilaginous, bony or
adipose features (9).
Ultra structural examination has shown that
ductular cells in pleomorphic adenoma have
the characteristic of ductular cells of the
normal, and that the stromal cells retain
epithelial features in the from of
tonifilaments and desmosomes, although
occasional cells show myoepithelial features
with this filaments and dense bodies
(7,8,9,10).
In our two cases also, surgery was
performed through the lateral orbitotomy
with complete resection of tumor.
Ar
ch
ive
of
SI
Discussion
Patients with lacrimal gland benign mixed
tumor present with a progressive painless
downward and inward displacement of the
globe with axial proptosis. Symptoms are
usually present for more than 12 months.
A firm lobular mass may be palpated near
the superior lateral orbital rim, and orbital
imaging often reveals enlargement or
expansion of the lacrimal fossa. On CT Scan
the lesion appears well circumscribed but
may have a slightly nodular configuration.
Microscopic examination shows varied
cellular structure consisting primarily of
proliferations of benign epithelial cells and a
steroma composed of spindle-shaped cells
with occasional cartilaginous, mucinous, or
even osteoid degeneration or metaplasia.
This variability accounts for the mixed
tumor characterization of this lesion.
A pseudocapsule circumscribes the lesion,
but microscopic nodular extensions into the
pseudocapsule account for the tendency of
the lesion to recur if an appropriate margin
of surrounding orbital tissue is not also
removed at the time of excision.
Treatment should consist of complete
removal of the tumor with its pseudocapsule
and a surrounding margin of orbital tissue
without a preliminary biopsy.
If the capsule of the pleomorphic adenoma is
incised for direct biopsy, there is a 32% rate
of recurrence, and these recurrences have a
significant risk of malignant degeneration.
Analysis of the clinical presentation of the
lesion and its CT contour helps the surgeon
determine if the lesion is likely to be a
benign mixed tumor, in which case lateral
orbitotomy
is required for complete
excision as the initial approach.There are
confidential research results that show
incomplete resection of epithelial lacrimal
gland tumors and incisional biopsy of these
lesions is hazardous for patients (1).
If there are sufficient clinical and
radiological criteria leading to encapsulated
12
www.SID.ir
SI
References
ive
of
Ar
ch
13
www.SID.ir
www.SID.ir
ive
ch
Ar
of
SI
No.41, Autumn-2005
*********
:
. 39
SI
.
6 ) 3(
. .
of
.
.
ive
ch
Ar
www.SID.ir
14